| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO
1 company
Patel Dinesh V Ph D is a President and CEO at PTGX. Recent filings cover 2 purchases and 32 sales. Those positions are worth an estimated $75.4M at current prices.
Our model assigns Patel Dinesh V Ph D a below-average insider score of 34/100, based on 14 past trades. Over a 12-month horizon, 8.3% of those trades were profitable, with an average 12-month return of -72.1%.
Patel Dinesh V Ph D's largest disclosed position is in PTGX as President and CEO, worth about $75.4M. The recent filings there lean toward selling, a net 814,359 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | PTGX Protagonist Therapeutics, Inc. | President and CEO | Sale+OE10b5-1 | 125,000 | $145.92 | $18,240,567.82 | -19.3% | - | - | |
| Aug 11, 2026 | PTGX Protagonist Therapeutics, Inc. | President and CEO | Sale+OE10b5-1 | 100,000 | $148.91 | $14,890,798.99 | -16.0% | - | - | |
| May 12, 2026 | PTGX Protagonist Therapeutics, Inc. | President and CEO | Sale+OE | 75,000 | $100.12 | $7,509,000.00 | -12.5% | +50.1% | - | |
| Mar 25, 2026 | PTGX Protagonist Therapeutics, Inc. | President and CEO | Sale+OE | 54,700 | $101.00 | $5,524,700.00 | -9.4% | +14.0% | - | |
| Jan 27, 2026 | PTGX Protagonist Therapeutics, Inc. | President and CEO | Sale+OE | 48,273 | $84.18 | $4,063,743.02 | -7.8% | +18.6% | - | |
| Jan 20, 2026 | PTGX Protagonist Therapeutics, Inc. | President and CEO | Sell | 34,438 | $82.48 | $2,840,446.24 | -5.6% | +26.4% | - | |
| Jul 25, 2025 | PTGX Protagonist Therapeutics, Inc | President and CEO | Sell | 10,415 | $54.78 | $570,533.70 | -2.0% | +34.2% | +146.8% | |
| Jul 23, 2025 | PTGX Protagonist Therapeutics, Inc | President and CEO | Sell | 52,444 | $54.92 | $2,880,043.79 | -9.0% | +38.4% | +149.9% | |
| Feb 19, 2025 | PTGX Protagonist Therapeutics, Inc | President and CEO | Sell | 5,359 | $38.18 | $204,606.62 | -1.0% | +21.0% | +115.7% | |
| Nov 26, 2024 | PTGX Protagonist Therapeutics, Inc | President and CEO | Sale+OE | 100,000 | $46.81 | $4,680,749.20 | -19.7% | -19.7% | +100.9% |